<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/46039/taro-pharmaceutical-industries-ltd-adr/rss" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Sun in the shade</title>
			<link>https://www.valueresearchonline.com/stories/30034/sun-in-the-shade/</link>
			<pubDate>Wed, 20 Jan 2016 12:46:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Sun Pharma has fallen some 40 per cent from its 52-week highs. What ails the country&#039;s largest pharmaceutical company and what&#039;s ahead></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/30034/sun-in-the-shade/</guid>
		</item>
		<item>
			<title>Sunny days ahead</title>
			<link>https://www.valueresearchonline.com/stories/29602/sunny-days-ahead/</link>
			<pubDate>Fri, 11 Dec 2015 11:42:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>The fall in profitability after the Ranbaxy acquisition may have weighed  heavily upon investors but it&#039;s just a matter of time that the company turns around its acquisitions></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29602/sunny-days-ahead/</guid>
		</item>
    </channel>
</rss>
